For IHC testing, of the 812 CRC cases collected, 753 cases were HER2-negative, and 59 were confirmed to be HER2-positive (IHC 1+, IHC 2+, IHC 3+). The gene discussed is ERBB2; the disease is colorectal carcinoma.